Advanced Clinical Moves Clinical Trials from Feasibility to Optimization and Viability through a Proven Framework

Share Article

Advanced Clinical, a leading provider of clinical research services, moves clinical trials from feasibility to optimization and viability through its proven framework designed for venture capital (VC) target companies.

We have built on typical due diligence methods to ensure that a VC’s investment is also able to capture strong returns and gain access to breakthrough products through a robust assessment approach.

Advanced Clinical, a leading provider of clinical research services, moves clinical trials from feasibility to optimization and viability through its proven framework designed for venture capital (VC) target companies.

With the American Recovery and Reinvestment Act (ARRA) came the rise of Comparative Effectiveness Research (CER) to drive cost savings in health care as well as ensure less confusion about therapies. CER was funded to the tune of $1.1 billion in 2009. While the name of CER was updated in March 2010 to Patient-Centered Outcomes Research (PCOR), the focus is still on comparative effectiveness. Given PCOR as well as the tightening of investment dollars, VCs have increased their deal scrutiny.

In response, VCs have to look beyond feasibility assessments of the target company’s portfolios and creating associated financial models. Now, the highest return for VCs is captured based on three key elements: operational efficiency of the company, strong differentiation of pipeline products (comparative effectiveness), and the medical/scientific soundness of clinical development plans and protocols. Advanced Clinical has created the Optimization and Viability framework to assess the operational, comparative effectiveness and medical/scientific stance of VC target companies.

“We have built on typical due diligence methods to ensure that a VC’s investment is also able to capture strong returns and gain access to breakthrough products through a robust assessment approach,” said Rosemarie Truman, Executive Vice President of Advanced Clinical and thought leader of the Optimization and Viability methodology.

Advanced Clinical recently launched its proprietary Industry Leading R&D Performance (ILRDP) framework, which houses the components within the Optimization and Viability methodology. Methods within the framework are constantly refined based on new leading practices.

About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, “One Team” approach. To learn more, visit http://www.advancedclinical.com.

Contact:
Rosemarie Truman
rtruman(at)advancedclinical(dot)com
1200 Lakeside Drive
Bannockburn, IL 60015
Ph: 202-438-2208

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rosemarie Truman
Visit website